CLINICAL_TRIALS
research
· 2025-02-14
Clinical Trial Update: Comparing Rezum and Urolift [NA]
Summary
A clinical trial sponsored by the Chinese University of Hong Kong comparing Rezum and UroLift is currently recruiting for prostate cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese University of Hong Kong | Conditions: Prostate Cancer | NA | Status: RECRUITING